Zurcher Kantonalbank (Zurich Cantonalbank) Alaunos Therapeutics, Inc. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$34.1 Billion
Q4 2024

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$0.41 - $1.24 $13,576 - $41,061	-33,114 Closed	0 $0
Q1 2021 May 03, 2021	BUY	$2.82 - $5.6 $33,400 - $66,326	11,844 Added 55.68%	33,114 $119,000
Q1 2020 May 06, 2020	BUY	$1.9 - $4.98 $24,973 - $65,457	13,144 Added 161.75%	21,270 $52,000
Q1 2018 May 03, 2018	SELL	$3.46 - $5.14 $112,256 - $166,762	-32,444 Reduced 79.97%	8,126 $32,000
Q4 2017 Jan 31, 2018	BUY	$4.0 - $6.54 $18,608 - $30,424	4,652 Added 12.95%	40,570 $168,000
Q3 2017 Nov 08, 2017	BUY	$4.99 - $6.57 $179,230 - $235,981	35,918	35,918 $221,000

Others Institutions Holding TCRT

# of Institutions

Shares Held

92.6K

Call Options Held

Put Options Held

View Full List

About Alaunos Therapeutics, Inc.

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $359M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

More about TCRT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account